NDC 0078-0925

Maxidex

Dexamethasone

Maxidex is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Dexamethasone.

• Product ID: 0078-0925_603f0bac-16b8-42f5-985e-fb0d73ee284d
• NDC: 0078-0925
• Product Type: Human Prescription Drug
• Proprietary Name: Maxidex
• Generic Name: Dexamethasone
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 1966-05-15
• Marketing Category: NDA /
• Application Number: NDA013422
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: DEXAMETHASONE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-0925-25

5 mL in 1 BOTTLE (0078-0925-25)

• Marketing Start Date: 2022-07-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Maxidex" or generic name "Dexamethasone"

NDC	Brand Name	Generic Name
0998-0615	Maxidex	Maxidex
0054-3177	Dexamethasone	Dexamethasone
0054-4179	Dexamethasone	Dexamethasone
0054-4180	Dexamethasone	Dexamethasone
0054-4181	Dexamethasone	Dexamethasone
0054-4182	Dexamethasone	Dexamethasone
0054-4183	Dexamethasone	Dexamethasone
0054-4184	Dexamethasone	Dexamethasone
0054-4186	Dexamethasone	Dexamethasone
0054-8174	Dexamethasone	Dexamethasone
0023-3348	OZURDEX	dexamethasone